There isn't a lot of stock (float) on the US Nasdaq market. Most of the stock is over on the Tel Aviv exchange. Not surprising, as RDHL is an Israeli company. I've noticed that the day's price action tends to follow the TASE. That being the case, wouldn't be surprised to see RDHL trade back toward flat by the end of the day. TASE spiked up sharply, but was actually ended down slightly.
And he had ample opportunity to sell for a triple or during the run up in the weeks following the news he had taken a position. Trading volume more than adequate to cover closing the position out. Did he, or does he see ABEO as a longer time investment? You'll have to wait for his next 13F filing to find out.
That's an August, 2009 court document. Got anything that remotely applies to the company and it's business model today?
That language is pulled from an October 13 PR. Got anything newer to show that Stem prevailed?
May not be mentioned in the 8K, but it is prominently mentioned in the CUR PR announcing the move. Since you accessed the 8K, assume you'll have no problem accessing the PR.
Actually a long - my take is based on having seen many moves to a smaller cap market prior to financial issues and sometimes a reverse split. FWIW, I emailed Larry Smith (SOS) for his take, and he saw the move as a positive, but minor compared to the drug's potential.
Not a rumor. Check the PTBI news.
" Soros reported purchasing 1,166,667 shares of PlasmaTech Biopharmaceuticals on April 22. In the fourth quarter, he had purchased 250,000 shares of the company."
That what started the panic run up from $2.77 to $10. Momentum guys piled in and ran the SP up much further than the fundamentals warranted. Now they've left and the SP has declined back to a more reasonable level.
I believe you've confused the main Nasdaq market with the Nasdaq Capital Market. Not as positive a move as if the move was to the big Nasdaq.
DEFINITION of 'Nasdaq SmallCap Market'
The Nasdaq equity market for companies that have relatively small levels of market capitalization. Listing requirements for such "small cap" companies on the Nasdaq SmallCap Market are less stringent than for other Nasdaq markets that list larger companies with significantly higher market capitalization. In 2005, the Nasdaq SmallCap Market was renamed the Nasdaq Capital Market in order to reflect its core function of raising capital.
The Nasdaq Capital Market makes it relatively easier for early-stage companies to get listed compared to other senior exchanges with more onerous requirements. In order to list initially on the Nasdaq Capital Market, companies must meet all of the criteria under at least one of three listing standards - the equity standard, the market value of listed securities standard, or the total assets/total revenue standard.